uric acid has been researched along with Pulmonary Hypertension in 35 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Obesity, lipids, glucose tolerance and insulin resistance are risk factors for numerous cardiovascular diseases and are often accompanied by a considerable increase in serum uric acid (SUA) concentrations." | 9.94 | Insights into the relationship between serum uric acid and pulmonary hypertension (Review). ( Chen, M; He, Y; Lei, W; Luo, H; Shui, X; Zheng, J; Zhou, Y, 2024) |
| "Previous studies have suggested an association between uric acid (UA) and the severity of pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease pathogenesis." | 8.02 | Serum and pulmonary uric acid in pulmonary arterial hypertension. ( Akagi, S; Berrebeh, N; Boucly, A; Chaouat, A; Cottin, V; Cumont, A; Fadel, E; Guignabert, C; Huertas, A; Humbert, M; Jaïs, X; Jutant, EM; Le Vely, B; Mercier, O; Montani, D; Phan, C; Savale, L; Sitbon, O; Tamura, Y; Thuillet, R; Tromeur, C; Tu, L, 2021) |
| "There are studies reporting that uric acid elevation is a marker for hypoxemia and pulmonary hypertension secondary to some diseases." | 8.02 | The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale. ( Güllü, YT; Güven Atici, A; Kir, E; Köksal, N; Tunçez, İH, 2021) |
| "The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE)." | 7.83 | Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study. ( Amezcua-Guerra, LM; Castillo-Martínez, D; Juárez, M; Lozada-Navarro, AC; Marroquín-Fabián, E; Mora-Ramírez, M; Sánchez-Muñoz, F; Sandoval, J; Vargas-Barrón, J, 2016) |
| " Uric acid (UA) has been shown to be elevated in patients with pulmonary hypertension (PH) and heart failure." | 7.77 | Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. ( Dimitroula, H; Dimitroulas, T; Giannakoulas, G; Karvounis, H; Parcharidou, D; Settas, L; Sfetsios, T, 2011) |
| "A high serum uric acid is common in subjects with pulmonary hypertension." | 7.76 | Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? ( Block, ER; Johnson, RJ; Lanaspa, M; Patel, JM; Swenson, ER; Zharikov, SI, 2010) |
| " Obesity, lipids, glucose tolerance and insulin resistance are risk factors for numerous cardiovascular diseases and are often accompanied by a considerable increase in serum uric acid (SUA) concentrations." | 5.94 | Insights into the relationship between serum uric acid and pulmonary hypertension (Review). ( Chen, M; He, Y; Lei, W; Luo, H; Shui, X; Zheng, J; Zhou, Y, 2024) |
| "Increased oxidative stress and high uric acid are implicated in the pathogenesis of pulmonary hypertension (PH)." | 4.12 | Allopurinol treatment reduced vascular remodeling and improved vascular functions in monocrotaline-induced pulmonary hypertensive rats. ( Gokcen, T; Inci, EE; Inci, K; Serdar, U; Sevgen, O, 2022) |
| "Previous studies have suggested an association between uric acid (UA) and the severity of pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease pathogenesis." | 4.02 | Serum and pulmonary uric acid in pulmonary arterial hypertension. ( Akagi, S; Berrebeh, N; Boucly, A; Chaouat, A; Cottin, V; Cumont, A; Fadel, E; Guignabert, C; Huertas, A; Humbert, M; Jaïs, X; Jutant, EM; Le Vely, B; Mercier, O; Montani, D; Phan, C; Savale, L; Sitbon, O; Tamura, Y; Thuillet, R; Tromeur, C; Tu, L, 2021) |
| "There are studies reporting that uric acid elevation is a marker for hypoxemia and pulmonary hypertension secondary to some diseases." | 4.02 | The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale. ( Güllü, YT; Güven Atici, A; Kir, E; Köksal, N; Tunçez, İH, 2021) |
| "The objective of this paper is to assess whether pulmonary hypertension (PH) may be detected at one point in time or longitudinally predicted by serum uric acid (sUA) levels in systemic lupus erythematosus (SLE)." | 3.83 | Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study. ( Amezcua-Guerra, LM; Castillo-Martínez, D; Juárez, M; Lozada-Navarro, AC; Marroquín-Fabián, E; Mora-Ramírez, M; Sánchez-Muñoz, F; Sandoval, J; Vargas-Barrón, J, 2016) |
| " Uric acid (UA) has been shown to be elevated in patients with pulmonary hypertension (PH) and heart failure." | 3.77 | Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study. ( Dimitroula, H; Dimitroulas, T; Giannakoulas, G; Karvounis, H; Parcharidou, D; Settas, L; Sfetsios, T, 2011) |
| "A high serum uric acid is common in subjects with pulmonary hypertension." | 3.76 | Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension? ( Block, ER; Johnson, RJ; Lanaspa, M; Patel, JM; Swenson, ER; Zharikov, SI, 2010) |
| "In the Pulmonary Hypertension Center at the University of Colorado Health Sciences Center between September 1991 and August 1997, 442 consecutive patients were evaluated with right heart catheterization; 191 patients also had a measurement of the serum uric acid (UA) in close temporal proximity to the hemodynamic evaluation." | 3.70 | Hyperuricemia in severe pulmonary hypertension. ( Badesch, DB; Groves, BM; Voelkel, MA; Voelkel, NF; Wynne, KM, 2000) |
| "Pulmonary hypertension (PH) is common in obstructive sleep apnea syndrome (OSAS)." | 1.91 | Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome. ( Uyar, M, 2023) |
| "Patients with myelofibrosis had echocardiographic evidence of PH more often than patients with other MPNs (p < 0." | 1.56 | Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm. ( Akgun-Cagliyan, G; Kaya, E; Kilic, O; Ozen, F; Senol, H; Yaylali, YT; Yilmaz, S, 2020) |
| "Chronic hypoxic pulmonary hypertension is characterized by vasoconstriction and vascular remodeling and impaired endothelial nitric oxide (NO) production." | 1.35 | Ischemic and peroxynitrite preconditioning effects in chronic hypoxic rat lung. ( Demiryurek, AT; Gumusel, B; Turan, NN; Yildiz, G, 2008) |
| "Patients without pneumonitis had a significantly higher RVSP value than those with pneumonitis (77." | 1.33 | Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan. ( Chen, CH; Chen, HA; Chou, CT; Huang, DF; Liao, HT; Wang, HP, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.71) | 18.2507 |
| 2000's | 10 (28.57) | 29.6817 |
| 2010's | 16 (45.71) | 24.3611 |
| 2020's | 7 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gokcen, T | 1 |
| Inci, K | 1 |
| Inci, EE | 1 |
| Sevgen, O | 1 |
| Serdar, U | 1 |
| Chen, Q | 3 |
| Luo, H | 4 |
| Li, Y | 3 |
| Uyar, M | 1 |
| Zhou, Y | 1 |
| Chen, M | 1 |
| Zheng, J | 1 |
| Shui, X | 1 |
| He, Y | 1 |
| Lei, W | 1 |
| Yaylali, YT | 1 |
| Yilmaz, S | 1 |
| Akgun-Cagliyan, G | 1 |
| Kilic, O | 1 |
| Kaya, E | 1 |
| Senol, H | 1 |
| Ozen, F | 1 |
| Savale, L | 1 |
| Akagi, S | 1 |
| Tu, L | 1 |
| Cumont, A | 1 |
| Thuillet, R | 1 |
| Phan, C | 1 |
| Le Vely, B | 1 |
| Berrebeh, N | 1 |
| Huertas, A | 1 |
| Jaïs, X | 1 |
| Cottin, V | 1 |
| Chaouat, A | 1 |
| Tromeur, C | 1 |
| Boucly, A | 1 |
| Jutant, EM | 1 |
| Mercier, O | 1 |
| Fadel, E | 1 |
| Montani, D | 1 |
| Sitbon, O | 1 |
| Humbert, M | 1 |
| Tamura, Y | 2 |
| Guignabert, C | 1 |
| Kir, E | 1 |
| Güven Atici, A | 1 |
| Güllü, YT | 1 |
| Köksal, N | 1 |
| Tunçez, İH | 1 |
| Uk Kang, T | 1 |
| Park, KY | 1 |
| Kim, HJ | 1 |
| Ahn, HS | 1 |
| Yim, SY | 1 |
| Jun, JB | 1 |
| Mohamed, AAA | 1 |
| Hammam, N | 1 |
| El Zohri, MH | 1 |
| Gheita, TA | 1 |
| Rhodes, CJ | 1 |
| Wharton, J | 1 |
| Wilkins, MR | 1 |
| Kim, KJ | 1 |
| Baek, IW | 1 |
| Park, YJ | 1 |
| Yoon, CH | 1 |
| Kim, WU | 1 |
| Cho, CS | 1 |
| Dhaun, N | 1 |
| Vachiery, JL | 1 |
| Benza, RL | 1 |
| Naeije, R | 1 |
| Hwang, LJ | 1 |
| Liu, X | 1 |
| Teal, S | 1 |
| Webb, DJ | 1 |
| Bossone, E | 1 |
| Rudski, LG | 1 |
| Grünig, E | 1 |
| Rich, JD | 1 |
| Rich, S | 1 |
| Jasiewicz, M | 1 |
| Knapp, M | 1 |
| Waszkiewicz, E | 1 |
| Ptaszynska-Kopczynska, K | 1 |
| Szpakowicz, A | 1 |
| Sobkowicz, B | 1 |
| Musial, WJ | 1 |
| Kaminski, KA | 1 |
| Castillo-Martínez, D | 1 |
| Marroquín-Fabián, E | 1 |
| Lozada-Navarro, AC | 1 |
| Mora-Ramírez, M | 1 |
| Juárez, M | 1 |
| Sánchez-Muñoz, F | 1 |
| Vargas-Barrón, J | 1 |
| Sandoval, J | 1 |
| Amezcua-Guerra, LM | 1 |
| Pattathu, J | 1 |
| Gorenflo, M | 1 |
| Hilgendorff, A | 1 |
| Koskenvuo, JW | 1 |
| Apitz, C | 1 |
| Hansmann, G | 1 |
| Alastalo, TP | 1 |
| Leberkühne, LJ | 1 |
| Ploegstra, MJ | 1 |
| Douwes, JM | 1 |
| Bartelds, B | 1 |
| Roofthooft, MT | 2 |
| Hillege, HL | 1 |
| Berger, RM | 2 |
| Turan, NN | 1 |
| Yildiz, G | 1 |
| Gumusel, B | 1 |
| Demiryurek, AT | 1 |
| Jiang, X | 1 |
| Han, ZY | 1 |
| Wang, Y | 1 |
| Xu, XQ | 1 |
| Ma, CR | 1 |
| Wu, Y | 1 |
| Pan, L | 1 |
| Jing, ZC | 1 |
| Zharikov, SI | 1 |
| Swenson, ER | 1 |
| Lanaspa, M | 1 |
| Block, ER | 1 |
| Patel, JM | 1 |
| Johnson, RJ | 1 |
| Dimitroulas, T | 1 |
| Giannakoulas, G | 1 |
| Dimitroula, H | 1 |
| Sfetsios, T | 1 |
| Parcharidou, D | 1 |
| Karvounis, H | 1 |
| Settas, L | 1 |
| Yamada, Y | 1 |
| Okuda, S | 1 |
| Kataoka, M | 1 |
| Tanimoto, A | 1 |
| Abe, T | 1 |
| Okamura, T | 1 |
| Fukuda, K | 1 |
| Satoh, T | 2 |
| Kuribayashi, S | 1 |
| Andersen, CU | 1 |
| Mellemkjær, S | 1 |
| Nielsen-Kudsk, JE | 1 |
| Bendstrup, E | 1 |
| Simonsen, U | 1 |
| Hilberg, O | 1 |
| Li, ZN | 1 |
| He, JG | 1 |
| Liu, ZH | 1 |
| Gu, Q | 1 |
| Ni, XH | 1 |
| Cheng, XS | 1 |
| Xiong, CM | 1 |
| Wensel, R | 1 |
| Opitz, CF | 1 |
| Anker, SD | 1 |
| Winkler, J | 1 |
| Höffken, G | 1 |
| Kleber, FX | 1 |
| Sharma, R | 1 |
| Hummel, M | 1 |
| Hetzer, R | 1 |
| Ewert, R | 1 |
| Aubert, JD | 1 |
| O'Connell, KJ | 1 |
| Farah, MM | 1 |
| Chen, CH | 1 |
| Chen, HA | 1 |
| Wang, HP | 1 |
| Liao, HT | 1 |
| Chou, CT | 1 |
| Huang, DF | 1 |
| Pływaczewski, R | 1 |
| Bednarek, M | 1 |
| Jonczak, L | 1 |
| Górecka, D | 1 |
| Sliwiński, P | 1 |
| Njaman, W | 1 |
| Iesaki, T | 1 |
| Iwama, Y | 1 |
| Takasaki, Y | 1 |
| Daida, H | 1 |
| Van Albada, ME | 1 |
| Loot, FG | 1 |
| Fokkema, R | 1 |
| Hoeper, MM | 1 |
| Hohlfeld, JM | 1 |
| Fabel, H | 1 |
| Nagaya, N | 1 |
| Uematsu, M | 1 |
| Kyotani, S | 1 |
| Sakamaki, F | 1 |
| Nakanishi, N | 1 |
| Yamagishi, M | 1 |
| Kunieda, T | 1 |
| Miyatake, K | 1 |
| Voelkel, MA | 1 |
| Wynne, KM | 1 |
| Badesch, DB | 1 |
| Groves, BM | 1 |
| Voelkel, NF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University Hospital[NCT04843475] | 150 participants (Anticipated) | Observational | 2021-05-01 | Not yet recruiting | |||
| Biomarkers in Congenital Heart Diseases and Pulmonary Arterial Hypertension[NCT04130243] | 380 participants (Anticipated) | Observational [Patient Registry] | 2017-12-05 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for uric acid and Pulmonary Hypertension
| Article | Year |
|---|---|
Insights into the relationship between serum uric acid and pulmonary hypertension (Review).
Topics: Cardiovascular Diseases; Humans; Hypertension; Hypertension, Pulmonary; Hyperuricemia; Risk Factors; | 2024 |
Association of hyperuricemia and pulmonary hypertension: A systematic review and meta-analysis.
Topics: Female; Humans; Hypertension, Pulmonary; Hyperuricemia; Male; Middle Aged; Odds Ratio; Prognosis; Ur | 2019 |
Pulmonary hypertension: biomarkers.
Topics: Angiopoietins; Animals; Biomarkers; Genetic Markers; Growth Differentiation Factor 15; Humans; Hyper | 2013 |
Clinical diagnosis of pulmonary hypertension.
Topics: Age Distribution; Age of Onset; Cardiac Catheterization; Diagnostic Techniques, Cardiovascular; Elec | 2014 |
Biochemical markers in the management of pulmonary hypertension.
Topics: Biomarkers; Humans; Hypertension, Pulmonary; Natriuretic Peptides; Nitric Oxide; Prognosis; Troponin | 2005 |
1 trial available for uric acid and Pulmonary Hypertension
| Article | Year |
|---|---|
Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: clinical associations.
Topics: Administration, Oral; Adolescent; Adult; Aged; Bosentan; Child; Dose-Response Relationship, Drug; Do | 2014 |
29 other studies available for uric acid and Pulmonary Hypertension
| Article | Year |
|---|---|
Allopurinol treatment reduced vascular remodeling and improved vascular functions in monocrotaline-induced pulmonary hypertensive rats.
Topics: Allopurinol; Animals; Hypertension, Pulmonary; Lung; Male; Monocrotaline; Pulmonary Artery; Rats; Ra | 2022 |
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Topics: Bilirubin; China; Diuretics; Humans; Hypertension, Pulmonary; Retrospective Studies; Tolvaptan; Uric | 2022 |
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Topics: Bilirubin; China; Diuretics; Humans; Hypertension, Pulmonary; Retrospective Studies; Tolvaptan; Uric | 2022 |
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Topics: Bilirubin; China; Diuretics; Humans; Hypertension, Pulmonary; Retrospective Studies; Tolvaptan; Uric | 2022 |
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Topics: Bilirubin; China; Diuretics; Humans; Hypertension, Pulmonary; Retrospective Studies; Tolvaptan; Uric | 2022 |
Impact of Pulmonary Hypertension on Renal Functions in Obstructive Sleep Apnea Syndrome.
Topics: Female; Glomerular Filtration Rate; Humans; Hypertension, Pulmonary; Kidney; Male; Renal Insufficien | 2023 |
Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm.
Topics: Adult; Aged; Bone Marrow Neoplasms; Echocardiography; Female; Humans; Hypertension, Pulmonary; Male; | 2020 |
Serum and pulmonary uric acid in pulmonary arterial hypertension.
Topics: Animals; Disease Models, Animal; Humans; Hypertension, Pulmonary; Lung; Monocrotaline; Pulmonary Art | 2021 |
The relationship between serum uric acid level and uric acid/creatinine ratio with chronic obstructive pulmonary disease severity (stable or acute exacerbation) and the development of cor pulmonale.
Topics: Creatinine; Humans; Hypertension, Pulmonary; Pulmonary Disease, Chronic Obstructive; Pulmonary Heart | 2021 |
Cardiac Manifestations in Systemic Lupus Erythematosus: Clinical Correlates of Subclinical Echocardiographic Features.
Topics: Adult; Blood Cell Count; Blood Sedimentation; Cholesterol; Echocardiography, Doppler; Female; Heart; | 2019 |
High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
Topics: Adult; Biomarkers; Blood Pressure; Comorbidity; Cross-Sectional Studies; Echocardiography; Female; H | 2015 |
Searching for markers of the right heart-pulmonary circulation unit function: a continuing challenge.
Topics: Antioxidants; Biomarkers; Creatinine; Echocardiography, Doppler; Hemodynamics; Humans; Hypertension, | 2014 |
Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage.
Topics: Cholesterol, LDL; Cytokine Receptor gp130; Follow-Up Studies; Hypertension, Pulmonary; Interleukin-6 | 2015 |
Levels of uric acid may predict the future development of pulmonary hypertension in systemic lupus erythematosus: a seven-year follow-up study.
Topics: Adult; Arterial Pressure; Biomarkers; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Hy | 2016 |
Genetic testing and blood biomarkers in paediatric pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DG
Topics: Activin Receptors, Type II; Adolescent; Antigens, CD; Atrial Natriuretic Factor; Biomarkers; Bone Mo | 2016 |
Serially Measured Uric Acid Levels Predict Disease Severity and Outcome in Pediatric Pulmonary Arterial Hypertension.
Topics: Biomarkers; Child; Female; Humans; Hypertension, Pulmonary; Male; Prognosis; Severity of Illness Ind | 2017 |
Ischemic and peroxynitrite preconditioning effects in chronic hypoxic rat lung.
Topics: Animals; Chronic Disease; Drug Antagonism; Drug Therapy, Combination; Enzyme Inhibitors; Hypertensio | 2008 |
Hemodynamic variables and clinical features correlated with serum uric acid in patients with pulmonary arterial hypertension.
Topics: Adolescent; Adult; Case-Control Studies; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male | 2008 |
Could uric acid be a modifiable risk factor in subjects with pulmonary hypertension?
Topics: Animals; Humans; Hypertension, Pulmonary; Hyperuricemia; Hypoxia; Models, Biological; Oxidative Stre | 2010 |
Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study.
Topics: Aged; Exercise; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pilot Projects; Pulmonar | 2011 |
Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.
Topics: Adult; Antihypertensive Agents; Biomarkers; Epoprostenol; Exercise Test; Exercise Tolerance; Familia | 2012 |
Diagnostic and prognostic role of biomarkers for pulmonary hypertension in interstitial lung disease.
Topics: Biomarkers; Cross-Sectional Studies; Fibrin Fibrinogen Degradation Products; Humans; Hypertension, P | 2012 |
[Relationship between serum uric acid levels and patient conditions and prognosis in idiopathic pulmonary arterial hypertension].
Topics: Adult; Endothelin-1; Female; Humans; Hypertension, Pulmonary; Male; Natriuretic Peptide, Brain; Prog | 2012 |
Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.
Topics: Exercise Test; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middl | 2002 |
A 4-month-old with urate crystals and failure to thrive.
Topics: Failure to Thrive; Fatal Outcome; Humans; Hypertension, Pulmonary; Infant; Male; Resuscitation; Uric | 2006 |
Pulmonary arterial hypertension in autoimmune diseases: an analysis of 19 cases from a medical center in northern Taiwan.
Topics: Adult; Aged; Antibodies, Antinuclear; Autoimmune Diseases; Female; Hospitals; Humans; Hypergammaglob | 2006 |
[Hyperuricaemia in females with obstructive sleep apnoea].
Topics: Aged; Body Mass Index; Comorbidity; Estrogens; Female; Humans; Hypertension, Pulmonary; Hyperuricemi | 2006 |
Serum uric Acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease.
Topics: Biomarkers; Connective Tissue Diseases; Echocardiography; Female; Humans; Hypertension, Pulmonary; K | 2007 |
Biological serum markers in the management of pediatric pulmonary arterial hypertension.
Topics: Adolescent; Biomarkers; Blood Pressure; Cardiac Output; Cardiovascular Agents; Child; Child, Prescho | 2008 |
Hyperuricaemia in patients with right or left heart failure.
Topics: Adult; Aged; Arthritis, Gouty; Cardiomyopathy, Dilated; Diuretics; Female; Hemodynamics; Humans; Hyp | 1999 |
Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension.
Topics: Adult; Cardiac Catheterization; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle | 1999 |
Hyperuricemia in severe pulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Biomarkers; Cardiac Catheterization; Colorimetry; Epoprostenol; Hear | 2000 |